NOTCH signaling on the underdeveloped cardiac vascularization of hypoplastic left heart syndrome in the hiPSC-derived vascularized cardiac organoids
NOTCH signaling on the underdeveloped cardiac vascularization of hypoplastic left heart syndrome in the hiPSC-derived vascularized cardiac organoids
批准号:
10439137
负责人:
Huaxiao Yang
金额:
$43.82万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-08 至 2025-08-31
关键词:
BMP10 geneBindingBlood VesselsBlood capillariesCRISPR/Cas technologyCalciumCardiacCardiac MyocytesCardiovascular systemCell LineCell modelCell physiologyCellsComplexDataDefectDevelopmentEGF geneERBB2 geneEndothelial CellsEndotheliumFetal HeartFunctional disorderGene ExpressionGoalsGrowth FactorHeartHeart DiseasesHeart ValvesHumanHypoplastic Left Heart SyndromeImageKnock-outLeft ventricular structureLigandsLinkMeasuresMediatingMesodermModelingMolecularMutationMyocardialMyocardiumNOTCH1 geneNRG1 geneNewborn InfantNitric OxideOrganoidsPalliative SurgeryPathogenesisPathway interactionsPatientsPostpartum PeriodProcessProteomeProteomicsProtocols documentationRegulationSignal PathwaySignal TransductionSmooth Muscle MyocytesStructureStudy modelsTissuesTransgenic MiceUp-RegulationValidationVascularizationVentricularangiogenesisascending aortacardiac vasculaturecardiogenesiscongenital heart disorderdensityendothelial dysfunctionendothelial stem cellextracellulargamma secretasegenetic variantgenome editinginduced pluripotent stem cellinhibitormalformationprogenitorreceptorreceptor bindingsingle-cell RNA sequencingsmall moleculethree dimensional cell culture
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Hypoplastic left heart syndrome (HLHS) is one of the most fatal congenital heart diseases (CHD) that occurs in
1 of every 4,344 newborns. The HLHS patients’ hearts show the severe underdevelopment of the left ventricle,
heart valves, and ascending aorta, and specifically lower capillary density in the myocardium. Moreover, the
genetic variant of NOTCH1 is implicated in HLHS patients showing the relevance to endocardial defects,
endothelial dysfunction, and NOTCH1 signaling pathways. However, how the NOTCH1 signaling determines
the underdevelopment of cardiac vasculature in the HLHS patients is still inconclusive. There is still a missing
link between the pathogenesis in the cardiovascular underdevelopment and dysfunction found in the HLHS
hearts and the NOTCH1 mutation. In this proposal, the genome-edited NOTCH1+/- hiPSCs will be co-
differentiated in an already optimized protocol into the vascularized cardiac organoid (VCO) with
cardiomyocytes, endothelial cells, smooth muscle cells, and other cardiac cells to recapitulate the
underdevelopment and dysfunction of the cardiovascular system in the early development of HLHS heart with
NOTCH1 mutation and to further delineate the pathogenesis of HLHS in the dynamic multicellular crosstalk of
cardiovascular cells via NOTCH-DLL-JAG receptor-ligand interactions. In the preliminary results, we observed
a reduced vascular formation with a smaller myocardial-like ring in VCO when NOTCH signaling was inhibited
by g-secretase inhibitor, and smaller organoid size was noticed in the NOTCH1+/- VCO compared to the
isogenic wildtype VCO. We will further explore the NOTCH1 signaling on vascular and cardiac formation in
VCOs by measuring the cardiovascular structure, proliferation, function, and corresponding gene expressions
(Aim 1). Moreover, our preliminary study also shows upregulation of NOTCH1 signaling via the NOTCH-DLL-
JAG ligand-receptor interactions in the VCO compared to the non-vascularized cardiac organoid by the single-
cell RNA-seq and ligand-receptor analysis. We will further investigate the ligand-receptor interactions and
pseudotime trajectories of NOTCH1 signaling in the process of NOTCH1+/- VCO formation. The proteome
profile over the HLHS VCO development will be uncovered by the proteomic analysis in correlation and
validation with the single-cell RNA-seq data (Aim 2). The completion of the proposed project will be for better
determining the NOTCH1 signaling-mediated multicellular crosstalk and downstream pathways of
underdeveloped cardiac vascularization in HLHS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: